Targeting muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development.

Saved in:
Bibliographic Details
Title: Targeting muscarinic receptors for the treatment of alcohol use disorders: Opportunities and hurdles for clinical development.
Authors: Walker LC; Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.; Florey Department of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia., Huckstep KL; Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.; Florey Department of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia., Becker HC; Charleston Alcohol Research Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.; Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina, USA., Langmead CJ; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.; Neuromedicines Discovery Centre, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia., Lawrence AJ; Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.; Florey Department of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia.
Source: British journal of pharmacology [Br J Pharmacol] 2024 Nov; Vol. 181 (22), pp. 4385-4398. Date of Electronic Publication: 2023 May 01.
Publication Type: Journal Article; Review
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1476-5381
DOI:10.1111/bph.16081